• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Bank Of America, Morgan Stanley And Other 3 Stocks To Watch Heading Into Tuesday

    7/16/24 3:08:43 AM ET
    $BAC
    $FBK
    $KYTX
    $MS
    Major Banks
    Finance
    Major Banks
    Finance
    Get the next $BAC alert in real time by email

    With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

    • Wall Street expects Bank of America Corporation (NYSE:BAC) to report quarterly earnings at 80 cents per share on revenue of $25.22 billion before the opening bell. Bank of America shares gained 0.1% to $41.94 in after-hours trading.
    • FB Financial Corporation (NYSE:FBK) posted better-than-expected results for its second quarter on Monday. FB Financial shares rose 0.5% to $43.03 in the after-hours trading session.
    • Analysts are expecting Morgan Stanley (NYSE:MS) to post quarterly earnings at $1.65 per share on revenue of $14.3 billion. The company will release earnings before the markets open. Morgan Stanley shares rose 0.8% to $106.14 in after-hours trading.

    Check out our premarket coverage here

    • Kyverna Therapeutics, Inc. (NASDAQ:KYTX) shares rose sharply in after-hours trading on Monday after the company announced it received FDA Regenerative Medicine Advanced Therapy designation for KYV-101 in the treatment of patients with refractory stiff-person syndrome. Kyverna Therapeutics shares surged 7.5% to $10.65 in the after-hours trading session.
    • Analysts expect UnitedHealth Group Incorporated (NYSE:UNH) to post quarterly earnings at $6.66 per share on revenue of $98.84 billion after the closing bell. UnitedHealth shares rose 0.9% to $519.99 in after-hours trading.

    Check This Out:

    • Over $18M Bet On This Tech Stock? Check Out These 4 Stocks Insiders Are Buying
    Get the next $BAC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BAC
    $FBK
    $KYTX
    $MS

    CompanyDatePrice TargetRatingAnalyst
    Kyverna Therapeutics Inc.
    $KYTX
    5/27/2025$5.00Neutral → Buy
    H.C. Wainwright
    UnitedHealth Group Incorporated
    $UNH
    5/21/2025$270.00Hold → Reduce
    HSBC Securities
    UnitedHealth Group Incorporated
    $UNH
    5/19/2025$308.00Buy → Hold
    TD Cowen
    Bank of America Corporation
    $BAC
    5/15/2025$53.00Buy
    TD Cowen
    UnitedHealth Group Incorporated
    $UNH
    5/14/2025Strong Buy → Mkt Perform
    Raymond James
    UnitedHealth Group Incorporated
    $UNH
    5/14/2025$350.00Buy → Neutral
    BofA Securities
    UnitedHealth Group Incorporated
    $UNH
    4/22/2025$490.00Buy → Hold
    HSBC Securities
    UnitedHealth Group Incorporated
    $UNH
    4/21/2025Buy → Hold
    Argus
    More analyst ratings

    $BAC
    $FBK
    $KYTX
    $MS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Kyverna Therapeutics upgraded by H.C. Wainwright with a new price target

      H.C. Wainwright upgraded Kyverna Therapeutics from Neutral to Buy and set a new price target of $5.00

      5/27/25 9:06:20 AM ET
      $KYTX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • UnitedHealth downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded UnitedHealth from Hold to Reduce and set a new price target of $270.00

      5/21/25 8:41:18 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth downgraded by TD Cowen with a new price target

      TD Cowen downgraded UnitedHealth from Buy to Hold and set a new price target of $308.00

      5/19/25 8:51:13 AM ET
      $UNH
      Medical Specialities
      Health Care

    $BAC
    $FBK
    $KYTX
    $MS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Bank of America Corporation

      SC 13D/A - BANK OF AMERICA CORP /DE/ (0000070858) (Filed by)

      12/13/24 4:29:10 PM ET
      $BAC
      Major Banks
      Finance
    • Amendment: SEC Form SC 13G/A filed by FB Financial Corporation

      SC 13G/A - FB Financial Corp (0001649749) (Subject)

      11/14/24 1:28:34 PM ET
      $FBK
      Major Banks
      Finance
    • SEC Form SC 13G filed by Kyverna Therapeutics Inc.

      SC 13G - Kyverna Therapeutics, Inc. (0001994702) (Subject)

      11/12/24 7:23:31 AM ET
      $KYTX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care

    $BAC
    $FBK
    $KYTX
    $MS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Kyverna Therapeutics to Present at the Jefferies Global Healthcare Conference

      EMERYVILLE, Calif., May 28, 2025 /PRNewswire/ -- Kyverna Therapeutics, Inc. ((Kyverna, NASDAQ:KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that Warner Biddle, Chief Executive Officer of Kyverna, will present at the Jefferies Global Healthcare Conference in New York, NY on Wednesday, June 4, 2025, at 4:55 p.m. ET. A live webcast of the presentation may be accessed via the Investors section of the Kyverna website at ir.kyvernatx.com. A replay of the webcast will be available on the w

      5/28/25 4:02:00 PM ET
      $KYTX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • BofA Report: 60% of Homeowners and Prospective Buyers Uncertain About the Housing Market - A Three-Year High

      Despite Uncertainty, Prospective Buyers Are Cautiously Optimistic About Market Improvements CHARLOTTE, N.C., May 28, 2025 /PRNewswire/ -- Uncertainty among current homeowners and prospective buyers is at a three-year high, with 60% saying they can't tell whether now is a good time to buy a home or not, compared to 48% two years ago, according to the latest Bank of America Homebuyer Insights Report (PDF), released in coordination with Bank of America Institute's latest On the move analysis. Despite this, 52% of prospective homebuyers are optimistic about the state of the homebu

      5/28/25 9:00:00 AM ET
      $BAC
      Major Banks
      Finance
    • Professional Guidance, Planning and Income Solutions Most-Wanted Retirement Benefits Amid Volatility: Morgan Stanley Retirement Study

      As financial stress rises, employees are cutting back on contributions to workplace retirement plans Access to financial advisors, planning support and retirement income solutions increasingly in demand Morgan Stanley at Work, together with Morgan Stanley Institutional Consulting Solutions which supports the retirement business, today announced retirement-focused data from its fifth-annual State of the Workplace Financial Benefits Study. Results show that while more employees are participating in their workplace retirement plans, they are also responding to economic uncertainty by cutting back on their account contributions and looking for financial guidance through the workplace. Add

      5/27/25 9:00:00 AM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance

    $BAC
    $FBK
    $KYTX
    $MS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President & CFO Rex John F bought $4,999,919 worth of shares (17,175 units at $291.12), increasing direct ownership by 9% to 203,796 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 6:11:47 PM ET
      $UNH
      Medical Specialities
      Health Care
    • CEO, UHG Hemsley Stephen J bought $25,019,019 worth of shares (86,700 units at $288.57), increasing direct ownership by 15% to 679,493 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 6:11:45 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Director Flynn Timothy Patrick bought $491,786 worth of shares (1,533 units at $320.80) (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 12:28:22 PM ET
      $UNH
      Medical Specialities
      Health Care

    $BAC
    $FBK
    $KYTX
    $MS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Vice Chair, Gl Stra & Ent Plat Nguyen Thong M gifted 215,000 shares and received a gift of 215,000 shares, decreasing direct ownership by 46% to 248,016 units (SEC Form 4)

      4 - BANK OF AMERICA CORP /DE/ (0000070858) (Issuer)

      5/28/25 4:53:56 PM ET
      $BAC
      Major Banks
      Finance
    • Director Jubran Raja J. was granted 1,376 shares, increasing direct ownership by 3% to 48,663 units (SEC Form 4)

      4 - FB Financial Corp (0001649749) (Issuer)

      5/28/25 12:19:46 PM ET
      $FBK
      Major Banks
      Finance
    • Director Pinson Charles Wright was granted 1,376 shares, increasing direct ownership by 6% to 23,692 units (SEC Form 4)

      4 - FB Financial Corp (0001649749) (Issuer)

      5/28/25 12:19:35 PM ET
      $FBK
      Major Banks
      Finance

    $BAC
    $FBK
    $KYTX
    $MS
    Leadership Updates

    Live Leadership Updates

    See more

    $BAC
    $FBK
    $KYTX
    $MS
    SEC Filings

    See more
    • UnitedHealth Group Investors: Please contact the Portnoy Law Firm to recover your losses. July 7, 2025 Deadline to file Lead Plaintiff Motion.

      Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) --  The Portnoy Law Firm advises UnitedHealth Group ("UnitedHealth" or the "Company") (NYSE:UNH) UnitedHealth investors have until July 7, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. UnitedHealth is a health insurance and health care services pr

      5/13/25 5:59:56 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Record $36 Million Raised for Charity at the 2024 Bank of America Chicago Marathon

      Runners Can Secure an Entry into the Sold-Out 2025 Event by Running and Fundraising for Charity CHICAGO, Jan. 28, 2025 /PRNewswire/ -- The Bank of America Chicago Marathon announced today that 2024 participants raised $36 million for local, national and global nonprofits, the highest fundraising total in event history. Since 2002, participants have raised more than $358 million through the event's official Charity Program. This feat is accomplished by participants who sign on to support an affiliated cause and commit to fundraising as a part of their marathon journey. Individuals hoping to take part in this year's sold-out event can still secure their place by committing to run and fundraise

      1/28/25 10:00:00 AM ET
      $BAC
      Major Banks
      Finance
    • Kyverna Therapeutics Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development Officer

      Dr. Gehchan brings decades of successful late-stage clinical development and commercial experience to role, further enhancing Kyverna's senior leadership team to execute Company's next wave of growth EMERYVILLE, Calif., Jan. 21, 2025 /PRNewswire/ -- Kyverna Therapeutics, Inc. ((Kyverna, NASDAQ:KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced the appointment of Naji Gehchan, M.D., MBA, to Chief Medical and Development Officer, where he will lead the Company's research, clinical development, and medical affairs functions. Dr. Gehchan brings 20 years of U.S. and international experience across multiple

      1/21/25 4:05:00 PM ET
      $KYTX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form FWP filed by Morgan Stanley

      FWP - MORGAN STANLEY (0000895421) (Subject)

      5/30/25 4:39:18 PM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form FWP filed by Morgan Stanley

      FWP - MORGAN STANLEY (0000895421) (Subject)

      5/30/25 4:13:13 PM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form FWP filed by Morgan Stanley

      FWP - MORGAN STANLEY (0000895421) (Subject)

      5/30/25 3:55:26 PM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance

    $BAC
    $FBK
    $KYTX
    $MS
    Financials

    Live finance-specific insights

    See more
    • BofA Report: 60% of Homeowners and Prospective Buyers Uncertain About the Housing Market - A Three-Year High

      Despite Uncertainty, Prospective Buyers Are Cautiously Optimistic About Market Improvements CHARLOTTE, N.C., May 28, 2025 /PRNewswire/ -- Uncertainty among current homeowners and prospective buyers is at a three-year high, with 60% saying they can't tell whether now is a good time to buy a home or not, compared to 48% two years ago, according to the latest Bank of America Homebuyer Insights Report (PDF), released in coordination with Bank of America Institute's latest On the move analysis. Despite this, 52% of prospective homebuyers are optimistic about the state of the homebu

      5/28/25 9:00:00 AM ET
      $BAC
      Major Banks
      Finance
    • Bank of America Announces Redemption of CHF 375 Million of 0.2525% Senior Notes, Due June 12, 2026

      CHARLOTTE, N.C., May 23, 2025 /PRNewswire/ -- Bank of America Corporation announced today that it will redeem on June 12, 2025 all CHF 375,000,000 principal amount outstanding of its 0.2525% Senior Notes, due June 12, 2026 (ISIN: CH0474977722; Common Code: 200733517) (the "Notes").  The Notes were issued under the Bank of America Corporation U.S. $65,000,000,000 Euro Medium-Term Note Program. The redemption price for the Notes will be equal to the Optional Redemption Amount of CHF 5,000 per CHF 5,000 Calculation Amount (as specified in the applicable Pricing Supplement dated J

      5/23/25 7:00:00 AM ET
      $BAC
      Major Banks
      Finance
    • QR Sign-Ins Surge 60% on BofA's CashPro® Platform

      Convenience, Security and Integration with Biometrics Drive Growth in Adoption of QR Sign-In Technology NEW YORK and LONDON and HONG KONG, May 20, 2025 /PRNewswire/ -- Every day, thousands of CFOs and treasurers use QR code technology to sign-in to CashPro, Bank of America's digital banking platform accessed by more than 40,000 corporate and commercial clients around the world to manage their treasury, trade and credit operations and perform self-service requests. The identity and authentication technology, introduced in 2022, recently surpassed two million uses and saw 60% growth in adoption over the last year1. "Nearly every business client uses CashPro as the

      5/20/25 9:05:00 AM ET
      $BAC
      Major Banks
      Finance